Efficacy and safety of uninterrupted periprocedural edoxaban in patients undergoing catheter ablation for atrial fibrillation: Prospective KYU-RABLE study

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Perspectives on anticoagulation across cardiovascular disease Anticoagulants ESC Premium Access ESC Congress 2019

ESC 365 is supported by

ESC 365 is supported by